Rethink: Channel Strategy for Oral Oncolytics
How manufacturers can benefit from provider-led care coordination to improve patient outcomes.
Helping Specialty Practices Bridge the Clinical Research Gap
How an innovative program efficiently and affordably connects patients with cutting-edge care and practices with elusive research opportunities
Information Exchange With Payers and Providers
What information do payers and providers want from pharma?
Ready or Not, MACRA Implementation Has Begun
Specialty practices must take action today to prepare for full MACRA implementation.
Health System Pharmacy and Population Health Management
By enhancing existing infrastructure and core assets with emerging technologies, pharmacy can be a driving force in an impactful population health management initiative.
A Look Ahead for Health System Pharmacy
Four key health system trends and the opportunities they present for pharmacy.
Ambulatory Pharmacy as the Hub of Transitional Care
How an effective meds-to-beds program and robust data analytics can improve care continuity and lower readmissions for successful value-based care.
Improving Patient Services and Outcomes With Data-Driven Design
How can data-driven service design improve patient support programs and outcomes?
Leveraging Data Analytics for the Value-based Care Transition
How community oncology practices can unlock the power of data for successful value-based care.
Transitional Care Pivots Toward Improved Performance
Analytics is trending in transitional care, with impressive results for high-risk patients.
Practical Data in an Insights-driven World
How should manufacturers be using distribution data to uncover insights and manage access?
Using Data to Improve Patient Interactions
Tom Mullin, President of Community and Specialty Pharmacy at AmerisourceBergen, shares how pharmacies are using data to improve interactions with patients.
The Truth Behind Three Health Systems Myths: Part Two
Leveraging data to get the total drug purchasing picture.
Five Oncology Trends Impacting the Patient Experience
New challenges to oncology product access, optimized clinical outcomes and commercial success, with strategic recommendations for how pharmaceutical manufacturers can support prescribers and patients through the continuum of cancer care.